Andreas Rank

4.2k total citations
86 papers, 2.2k citations indexed

About

Andreas Rank is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Andreas Rank has authored 86 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 30 papers in Hematology and 23 papers in Oncology. Recurrent topics in Andreas Rank's work include Immunotherapy and Immune Responses (19 papers), Immune Cell Function and Interaction (14 papers) and Platelet Disorders and Treatments (13 papers). Andreas Rank is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Immune Cell Function and Interaction (14 papers) and Platelet Disorders and Treatments (13 papers). Andreas Rank collaborates with scholars based in Germany, Netherlands and Austria. Andreas Rank's co-authors include Bettina Tóth, Rienk Nieuwland, Rudolf Pihusch, Susanne Liebhardt, Klaus Friese, Hans‐Jochem Kolb, Erhard Hiller, Andrés Fabián Lasagni, Christoph Schmid and Verena Pihusch and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andreas Rank

78 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Rank Germany 23 676 523 482 396 359 86 2.2k
Tomoyuki Endo Japan 26 519 0.8× 641 1.2× 548 1.1× 427 1.1× 691 1.9× 147 2.6k
John R. Krause United States 25 708 1.0× 319 0.6× 667 1.4× 579 1.5× 250 0.7× 127 2.4k
Joo Seop Chung South Korea 23 415 0.6× 296 0.6× 515 1.1× 290 0.7× 394 1.1× 101 1.8k
Kim Vettenranta Finland 31 1.0k 1.5× 571 1.1× 654 1.4× 193 0.5× 290 0.8× 167 3.4k
Takahisa Yamane Japan 22 683 1.0× 200 0.4× 444 0.9× 339 0.9× 354 1.0× 161 2.1k
David Simpson New Zealand 20 438 0.6× 271 0.5× 830 1.7× 1.3k 3.4× 329 0.9× 77 2.2k
Adrian Goycoolea 2 1.6k 2.4× 281 0.5× 796 1.7× 209 0.5× 556 1.5× 3 2.8k
Michael R. Bishop United States 25 1.3k 2.0× 358 0.7× 1.2k 2.5× 396 1.0× 707 2.0× 155 2.8k
Jeffrey Clarke United States 22 243 0.4× 565 1.1× 1.1k 2.2× 163 0.4× 262 0.7× 88 3.2k
Hans‐Joachim Stemmler Germany 27 275 0.4× 433 0.8× 2.0k 4.2× 128 0.3× 404 1.1× 97 3.4k

Countries citing papers authored by Andreas Rank

Since Specialization
Citations

This map shows the geographic impact of Andreas Rank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Rank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Rank more than expected).

Fields of papers citing papers by Andreas Rank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Rank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Rank. The network helps show where Andreas Rank may publish in the future.

Co-authorship network of co-authors of Andreas Rank

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Rank. A scholar is included among the top collaborators of Andreas Rank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Rank. Andreas Rank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rank, Andreas, et al.. (2025). Leukemia-Derived Dendritic Cells Induce Anti-Leukemic Effects Ex Vivo in AML Independently of Patients’ Clinical and Biological Features. International Journal of Molecular Sciences. 26(4). 1700–1700. 1 indexed citations
2.
Schmohl, Joerg Uwe, Marcus Hentrich, Peter Bojko, et al.. (2024). Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients’ Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays. International Journal of Molecular Sciences. 25(13). 6983–6983. 4 indexed citations
3.
Konrad, Maik, et al.. (2024). Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response. International Journal of Molecular Sciences. 25(10). 5056–5056. 3 indexed citations
4.
5.
Schmohl, Joerg Uwe, Andreas Rank, Klaus Hirschbühl, et al.. (2024). In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers. International Journal of Molecular Sciences. 25(24). 13469–13469. 3 indexed citations
6.
Schiele, Stefan, et al.. (2024). Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma. BMC Cancer. 24(1). 825–825. 1 indexed citations
7.
8.
Märkl, Bruno, Sebastian Dintner, Éva Sipos, et al.. (2023). Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA). Cancers. 15(3). 994–994. 18 indexed citations
9.
Rank, Andreas, Tobias L. Lenz, Teresa Trenkwalder, et al.. (2022). Echocardiographic evaluation of left ventricular function using an automated analysis algorithm is feasible for beginners and experts: comparison with invasive and non-invasive methods. Journal of Echocardiography. 21(2). 65–73. 3 indexed citations
10.
Schiele, Stefan, Rainer Claus, Christoph Römmele, et al.. (2021). Impact of age and gender on lymphocyte subset counts in patients with COVID‐19. Cytometry Part A. 103(2). 127–135. 14 indexed citations
11.
Trepel, Martin, et al.. (2020). Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer. Cancer Immunology Immunotherapy. 69(1). 147–157. 34 indexed citations
12.
Rank, Andreas, et al.. (2011). Clearance of platelet microparticles in vivo. Platelets. 22(2). 111–116. 97 indexed citations
13.
Rank, Andreas, et al.. (2011). Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women. Archives of Gynecology and Obstetrics. 285(4). 1035–1041. 15 indexed citations
14.
Rank, Andreas, Oliver Weigert, & Helmut Ostermann. (2010). Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Liebhardt, Susanne, Nina Ditsch, Rienk Nieuwland, et al.. (2010). CEA-, Her2/neu-, BCRP- and Hsp27-positive microparticles in breast cancer patients.. PubMed. 30(5). 1707–12. 32 indexed citations
16.
Rank, Andreas, Rienk Nieuwland, Anton Köhler, et al.. (2010). Cellular origin of platelet-derived microparticles in vivo. Thrombosis Research. 126(4). e255–e259. 33 indexed citations
17.
Tóth, Bettina, Rienk Nieuwland, Ni na Rogenhofer, et al.. (2008). ORIGINAL ARTICLE: Systemic Changes in Haemostatic Balance are not Associated with Increased Levels of Circulating Microparticles in Women with Recurrent Spontaneous Abortion. American Journal of Reproductive Immunology. 59(2). 159–166. 15 indexed citations
18.
Tóth, Bettina, Andreas Rank, Rienk Nieuwland, et al.. (2007). Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets. 18(7). 515–521. 71 indexed citations
19.
Pihusch, Verena, Andreas Rank, Markus Pihusch, et al.. (2006). Endothelial Cell–Derived Microparticles in Allogeneic Hematopoietic Stem Cell Recipients. Transplantation. 81(10). 1405–1409. 61 indexed citations
20.
Pihusch, Rudolf, et al.. (2002). Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. Journal of Hepatology. 37(5). 548–555. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoyuki Endo Breakdown of academic impact, for papers by John R. Krause Breakdown of academic impact, for papers by Joo Seop Chung Breakdown of academic impact, for papers by Kim Vettenranta Breakdown of academic impact, for papers by Takahisa Yamane Breakdown of academic impact, for papers by David Simpson Breakdown of academic impact, for papers by Adrian Goycoolea Breakdown of academic impact, for papers by Michael R. Bishop Breakdown of academic impact, for papers by Jeffrey Clarke Breakdown of academic impact, for papers by Hans‐Joachim Stemmler
Rankless by CCL
2026